HealWELL AI Inc

HEALWELL’s Orion Health Signs Memorandum of Understanding with Lean Business Services to Advance AI-Powered Healthcare in Saudi Arabia & Across the Middle East

  • HEALWELL AI and its subsidiary Orion Health have signed a Memorandum of Understanding (MoU) with Lean Business Services, to jointly explore the development and commercialization of digital health and AI-driven solutions across the Middle East and Orion’s global markets.

  • The MoU leverages complementary strengths across technology, innovation, and market access, focusing on AI driven population health, clinical AI, and data-interoperability.

  • Initial areas of collaboration include enhancing population health strategies and integrating world leading AI solutions into Saudi Arabia’s NPHIES platform.

TORONTO, ON, October 30, 2025 — HEALWELL AI Inc. (“HEALWELL” or the “Company“) (TSX: AIDX, OTCQX: HWAIF), a healthcare artificial intelligence company focused on preventative care, and its subsidiary Orion Health, have signed a Memorandum of Understanding (MoU) with Lean Business Services (“Lean”), from the Kingdom of Saudi Arabia (“the Kingdom”), to jointly explore digital health and artificial intelligence solutions in the Middle East and global markets.


Lean is a leading Saudi Arabian digital health technology company that provides data and interoperability solutions designed to power the Kingdom’s healthcare ecosystem. Lean supports national digital transformation initiatives through secure health data exchange, cloud services, and advanced health information systems, serving as a key enabler of Vision 2030’s healthcare objectives.


Previously in 2023, Lean partnered with Orion Health to deploy Saudi Arabia’s National Platform for Health and Insurance Exchange Services (“NPHIES”). NPHIES is the world’s largest health information exchange and has successfully unified digital infrastructure connecting healthcare providers, payers, and regulators to enable real-time, standards-based data exchange and interoperability across the Kingdom.


This MoU brings together HEALWELL’s advanced AI and clinical decision support tools, Lean’s innovation and market leadership in the Kingdom, and Orion Health’s proven interoperability and health information exchange technology. The three organizations will explore opportunities to co-develop, commercialize, and deploy next-generation healthcare solutions designed to improve population health outcomes and accelerate the adoption of AI in clinical workflows.


This signing establishes a framework for collaboration and aligns the organizations on shared priorities in technology development, regulatory alignment, and commercial execution. The MoU agreement was formally signed by Hamed Shahbazi, Executive Chairman of HEALWELL AI, and Mohanned Alrasheed, the CEO of Lean during the Global Health Exhibition in Riyadh on October 28, 2025.


“Our goal is not just to digitize healthcare, but to enable personalized, proactive care for every individual in the Kingdom,” said Mohanned Alrasheed, Chief Executive Officer of Lean Business Services. “By combining Lean’s national experience in building interoperable health systems with HEALWELL and Orion Health’s AI-driven capabilities, we are accelerating the next phase of connected, data-powered healthcare, one that reflects Saudi Arabia’s innovation leadership and supports both national priorities and global advancement.”


“This MoU represents a powerful alignment between three leaders in digital health,” said James Lee, CEO of HEALWELL AI. “By combining Lean’s market presence in the Kingdom, Orion Health’s global interoperability expertise, and HEALWELL’s AI-driven solutions, we are accelerating the transformation of healthcare in one of the world’s most dynamic and forward-looking regions.”


“We see the Middle East as a cornerstone market for digital health innovation,” said Brad Porter, CEO of Orion Health and Chief Commercial Officer of HEALWELL AI. “This collaboration builds on Orion Health’s long-standing presence and achievements in the region, such as the deployment of the Abu Dhabi and Saudi national health information exchanges and will inform the next generation of intelligent, data-driven healthcare solutions.”


Orion Health has been a pioneer in healthcare interoperability across the Middle East. In 2019, the company delivered Malaffi, the region’s first health information exchange in Abu Dhabi, now connecting more than 3,000 facilities, enabling access to clinical records for 13 million patients, and supporting 53,000 clinicians. In 2023, Orion Health supported the Kingdom of Saudi Arabia in deploying the world’s largest national HIE, connecting over 5,000 public and private providers and serving a population exceeding 30 million. These programs provide a strong foundation for the Lean × HEALWELL MoU to advance AI-powered healthcare across the region.

To further accelerate its growth and execution in the Middle East, HEALWELL has appointed Mr. Ayham Swed as Head of Sales and Business Development, Middle East, overseeing both HEALWELL and Orion Health’s regional initiatives. Mr. Ayham joins from Dedalus and has previously played a key role in Orion Health’s successes with the Malaffi and Saudi health information exchange programs.

James Lee
Chief Executive Officer
HEALWELL AI Inc.

About Lean

Lean Business Services, a PIF company, is the Kingdom’s leading provider of integrated health and wellbeing solutions. Through its work with national platforms such as Seha, Sehaty, and NPHIES, Lean plays a central role in advancing data interoperability, AI enablement, and preventative health innovation across Saudi Arabia’s healthcare ecosystem. The collaboration with HEALWELL AI and Orion Health aligns with Lean’s mission to extend Saudi Arabia’s digital health expertise globally, fostering sustainable partnerships that enhance the quality, accessibility, and intelligence of care delivery.

About HEALWELL AI

HEALWELL is a healthcare artificial intelligence company focused on preventative care. Its mission is to improve healthcare and save lives through early identification and detection of disease. Using its own proprietary technology, HEALWELL is developing and commercializing advanced clinical decision support systems that can help healthcare providers detect rare and chronic diseases, improve efficiency of their practice and ultimately help improve patient health outcomes. HEALWELL is executing a strategy centered around developing and acquiring technology and clinical sciences capabilities that complement its road map. HEALWELL is publicly traded on the Toronto Stock Exchange under the symbol “AIDX” and on the OTC Exchange under the symbol “HWAIF”. To learn more about HEALWELL, please visit https://healwell.ai/. 

Forward Looking Statements

Certain statements in this press release, constitute “forward-looking information” and “forward looking statements” (collectively, “forward looking statements”) within the meaning of applicable Canadian securities laws, including statements about HEALWELL’s plans to explore the development and commercialization of digital health and AI-driven solutions across the Middle East and Orion’s global markets;; and are based on assumptions, expectations, estimates and projections as of the date of this press release. Forward-looking statements are often, but not always, identified by words or phrases such as “explore”, “improve”, “accelerate” or variations of such words and phrases or statements that certain future conditions, actions, events or results “will”, “may”, “could”, “would”, “should”, “might” or “can” be taken, occur or be achieved, or the negative of any of these terms . Forward-looking statements are necessarily based upon management’s perceptions of historical trends, current conditions and expected future developments, as well as a number of specific factors and assumptions that, while considered reasonable by HEALWELL as of the date of such statements, are outside of HEALWELL’s control and are inherently subject to significant business, economic and competitive uncertainties and contingencies which could result in the forward-looking statements ultimately being entirely or partially incorrect or untrue. Forward looking statements contained in this press release are based on various assumptions, including, but not limited to, the following: HEALWELL’s ability to integrate its AI technologies into its other service offerings and platforms; HEALWELL’s ability to maintain and leverage its relationships with their commercial partners; the continued adoption of the software, tools and solutions created by HEALWELL and its subsidiaries; the stability of general economic and market conditions; sufficiency of working capital and access to financing; HEALWELL’s ability to comply with applicable laws and regulations; HEALWELL’s continued compliance with third party intellectual property rights; the effects of competition in the industry; the requirement for increasingly innovative product solutions and service offerings; technologies working as intended or at all; trends in customer growth and the adoption of new technologies in the industry; and that the risk factors noted below, collectively, do not have a material impact on

HEALWELL’s business, operations, revenues and/or results. By their nature, forward-looking statements are subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections, or conclusions will not prove to be accurate, that assumptions may not be correct, and that objectives, strategic goals and priorities will not be achieved.


Known and unknown risk factors, many of which are beyond the control of HEALWELL, could cause the actual results of HEALWELL to differ materially from the results, performance, achievements, or developments expressed or implied by such forward-looking statements. Such risk factors include but are not limited to those factors which are discussed under the section entitled “Risk Factors” in HEALWELL’s most recent annual information form dated March 31, 2025, which is available under HEALWELL’s SEDAR+ profile at www.sedarplus.ca. The risk factors are not intended to represent a complete list of the factors that could affect HEALWELL and the reader is cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking statements. There can be no assurance that forward looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Forward-looking statements are provided for the purpose of providing information about management’s expectations and plans relating to the future. HEALWELL disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, or to explain any material difference between subsequent actual events and such forward-looking statements, except to the extent required by applicable law. All of the forward-looking statements contained in this press release are qualified by these cautionary statements.

For more information:

Pardeep S. Sangha  
Investor Relations, HEALWELL AI Inc. 
Phone: 604-572-6392  
ir@healwell.ai 

Khure Health

Khure Health is a wholly owned subsidiary of HEALWELL AI. Khure is an AI health technology company whose precision medicine platform harnesses clinical data, enabling physicians to rapidly screen and identify patients with rare diseases and facilitate more personalized treatment.

Khure is actively working with and/or has rare and specialty disease programs in development with 6 of the top 10 pharma companies and international disease associations.
Visit Website →

This will close in 0 seconds

Pentavere

HEALWELL AI is a majority shareholder of Pentavere Research Group, a globally recognized and award-winning AI digital health company that has built a best-in-class AI engine to identify patients that are eligible for approved medications or interventions, to improve outcomes for patients and help drive therapy growth and penetration. Over the past several years, Pentavere has published an impressive array of literature in high-impact, peer-reviewed medical journals, totaling more than 30 manuscripts, which serve as a testament to Pentavere’s capabilities and adds significant credibility to their technology.
Visit Website →

This will close in 0 seconds

Intrahealth

Intrahealth is a pioneering force in healthcare technology, specializing in the development and implementation of state-of-the-art EMR solutions. With a relentless commitment to advancing patient care, Intrahealth empowers healthcare providers, institutions, and governments with innovative digital tools designed to enhance healthcare delivery and improve patient outcomes.
Visit Website →

This will close in 0 seconds

VeroSource Solutions

VeroSource Solutions is a digital health company established in 2014 to empower people and unlock the potential in Canadian healthcare. Its team of professionals has extensive experience in the full lifecycle of healthcare IT solutions and offers healthcare providers the technology and support needed to go digital. VeroSource’s cloud-first multi-channel software securely connects people, data and systems to drive digital healthcare transformation. Founded in Fredericton, NB, VeroSource has grown to include team members across Ontario and Atlantic Canadian.
Visit Website →

This will close in 0 seconds

BioPharma Services

BioPharma Services is a leading contract research organization (CRO) based in Toronto, Canada, specializing in Phase 1 and Phase 2a clinical trials. With a focus on scientific integrity, operational excellence, and adaptive processes tailored to each client’s needs, BioPharma Services has established a reputation for delivering high-quality results in the pharmaceutical and biotech industries. BioPharma’s comprehensive services also include Bioanalysis at their GLP Certified Laboratory, Scientific and Regulatory Affairs, Biostatistics and Safety Data Analysis (CDISC), Data Management and Medical Writing.
Visit Website →

This will close in 0 seconds

PolyClinic

HEALWELL AI Polyclinic provides onsite integrated health services including primary care, specialist care, lab services, and an in-house clinical research organization. With integrated systems and data-driven tools, HEALWELL AI Polyclinic plans to unlock meaningful insights from consistent, high-quality, structured clinical information from over 50 primary care physicians and specialists, labs, and clinical trials.
Visit Website →

This will close in 0 seconds

Doctorly

Founded in 2018, doctorly is a European based digital health-tech startup with a company mission of 'enabling people to live healthier lives'. With an initial focus on Europe’s largest market, Germany, doctorly has built a brand new, fully regulated practice management software to redefine how medical practices work. As an all-in-one solution, doctorly provides a fully centralised, cloud powered, GDPR compliant, medical practice operating system that dramatically reduces the time and effort doctors and medical assistants spend on day-to-day administrative tasks. doctorly is financially backed by some of the world’s most renowned venture capital firms. To learn more about doctorly please visit: www.doctorly.de

Read the original press release here.
Visit Website →

This will close in 0 seconds

xAI

xAI is a company working on building artificial intelligence to accelerate human scientific discovery. They're guided by their mission to advance our collective understanding of the universe. The team is led by Elon Musk, CEO of Tesla and SpaceX. Collectively their team has contributed some of the most widely used methods in the field, in particular the Adam optimizer, Batch Normalization, Layer Normalization, and the discovery of adversarial examples. They further introduced innovative techniques and analyses such as Transformer-XL, Autoformalization, the Memorizing Transformer, Batch Size Scaling, μTransfer, and SimCLR. They have worked on and led the development of some of the largest breakthroughs in the field including AlphaStar, AlphaCode, Inception, Minerva, GPT-3.5, and GPT-4. Learn more at https://x.ai/ Read the original press release here.
Visit Website →

This will close in 0 seconds

Mutuo Health Solutions

Mutuo Health Solutions is a Toronto-based medical artificial intelligence company focused on developing predictive clinical AI technology. Their flagship product, AutoScribe, is an advanced AI-powered ambient scribe solution that transcribes clinician-patient interactions into high-quality electronic medical records in real time. AutoScribe utilizes natural language processing and machine learning technology to accurately capture and structure patient data, enabling healthcare providers to focus on patient care and improve clinical efficiency.

Visit Website →

This will close in 0 seconds

Abstractive Health

Abstractive Health is on a mission to transform the healthcare industry by automating clinical documentation with generative AI. Their innovative AI software creates comprehensive patient summaries, streamlining workflows and empowering healthcare providers to focus on patient care. By harnessing advanced language models, the company delivers accurate, medically relevant insights directly to clinicians, enabling informed decision-making and improved patient outcomes. Read the original press release here. 

Visit Website →

This will close in 0 seconds